The effects of secondary prevention after coronary revascularization in Taiwan

BACKGROUND: Secondary prevention therapy for patients with coronary artery disease using an antiplatelet agent, β-blocker, renin-angiotensin system blocker (RASB), or statin plays an important role in the reduction of coronary events after coronary artery bypass grafting (CABG) surgery or percutaneo...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wen-Han, Chu, Chun-Yuan, Hsu, Po-Chao, Lee, Wen-Hsien, Su, Ho-Ming, Lin, Tsung-Hsien, Yen, Hsueh-Wei, Voon, Wen-Chol, Lai, Wen-Ter, Sheu, Sheng-Hsiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497233/
https://www.ncbi.nlm.nih.gov/pubmed/31048901
http://dx.doi.org/10.1371/journal.pone.0215811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497233/
https://www.ncbi.nlm.nih.gov/pubmed/31048901
http://dx.doi.org/10.1371/journal.pone.0215811

Ejemplares similares